These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 16404634

  • 1. Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
    Gupta A, Dai Y, Vethanayagam RR, Hebert MF, Thummel KE, Unadkat JD, Ross DD, Mao Q.
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):374-83. PubMed ID: 16404634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and functional analyses of breast cancer resistance protein in lung cancer.
    Kawabata S, Oka M, Soda H, Shiozawa K, Nakatomi K, Tsurutani J, Nakamura Y, Doi S, Kitazaki T, Sugahara K, Yamada Y, Kamihira S, Kohno S.
    Clin Cancer Res; 2003 Aug 01; 9(8):3052-7. PubMed ID: 12912956
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE.
    Clin Cancer Res; 2001 Jan 01; 7(1):145-52. PubMed ID: 11205902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models.
    Breedveld P, Pluim D, Cipriani G, Dahlhaus F, van Eijndhoven MA, de Wolf CJ, Kuil A, Beijnen JH, Scheffer GL, Jansen G, Borst P, Schellens JH.
    Mol Pharmacol; 2007 Jan 01; 71(1):240-9. PubMed ID: 17032904
    [Abstract] [Full Text] [Related]

  • 9. Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies.
    Zhou XF, Yang X, Wang Q, Coburn RA, Morris ME.
    Drug Metab Dispos; 2005 Aug 01; 33(8):1220-8. PubMed ID: 15908473
    [Abstract] [Full Text] [Related]

  • 10. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
    Gupta A, Zhang Y, Unadkat JD, Mao Q.
    J Pharmacol Exp Ther; 2004 Jul 01; 310(1):334-41. PubMed ID: 15007102
    [Abstract] [Full Text] [Related]

  • 11. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.
    Perego P, De Cesare M, De Isabella P, Carenini N, Beggiolin G, Pezzoni G, Palumbo M, Tartaglia L, Pratesi G, Pisano C, Carminati P, Scheffer GL, Zunino F.
    Cancer Res; 2001 Aug 15; 61(16):6034-7. PubMed ID: 11507048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y, Ishikawa E, Asada S, Sugimoto Y.
    Cancer Res; 2005 Jan 15; 65(2):596-604. PubMed ID: 15695404
    [Abstract] [Full Text] [Related]

  • 16. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y.
    Adv Drug Deliv Rev; 2009 Jan 31; 61(1):26-33. PubMed ID: 19111841
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M, O'Loughlin KL, Fricke SM, Williamson NA, Greco WR, Minderman H, Baer MR.
    Clin Cancer Res; 2005 Mar 15; 11(6):2320-6. PubMed ID: 15788683
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.
    Breast Cancer Res Treat; 2010 Oct 15; 123(3):679-89. PubMed ID: 19967559
    [Abstract] [Full Text] [Related]

  • 19. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH, Li G, Yu J, Xu MS, Liu ZX.
    Zhonghua Zhong Liu Za Zhi; 2011 Sep 15; 33(9):654-60. PubMed ID: 22340044
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.